ANL 30.35 Increased By ▲ 0.67 (2.26%)
ASC 20.20 Decreased By ▼ -0.02 (-0.1%)
ASL 24.81 Decreased By ▼ -0.17 (-0.68%)
BOP 8.32 Increased By ▲ 0.04 (0.48%)
BYCO 10.19 Decreased By ▼ -0.12 (-1.16%)
FCCL 22.05 Decreased By ▼ -0.15 (-0.68%)
FFBL 26.70 No Change ▼ 0.00 (0%)
FFL 20.36 Increased By ▲ 0.11 (0.54%)
FNEL 8.93 Decreased By ▼ -0.10 (-1.11%)
GGGL 27.35 Decreased By ▼ -0.05 (-0.18%)
GGL 46.30 Increased By ▲ 0.67 (1.47%)
HUMNL 7.16 Decreased By ▼ -0.12 (-1.65%)
JSCL 22.40 Increased By ▲ 0.55 (2.52%)
KAPCO 39.50 Decreased By ▼ -0.10 (-0.25%)
KEL 3.90 Decreased By ▼ -0.01 (-0.26%)
MDTL 3.60 Decreased By ▼ -0.04 (-1.1%)
MLCF 44.95 Decreased By ▼ -0.59 (-1.3%)
NETSOL 161.00 Decreased By ▼ -0.80 (-0.49%)
PACE 7.69 Increased By ▲ 0.24 (3.22%)
PAEL 33.36 Increased By ▲ 0.06 (0.18%)
PIBTL 11.15 No Change ▼ 0.00 (0%)
POWER 9.20 No Change ▼ 0.00 (0%)
PRL 23.88 Decreased By ▼ -0.02 (-0.08%)
PTC 12.09 Decreased By ▼ -0.03 (-0.25%)
SILK 1.80 Increased By ▲ 0.01 (0.56%)
SNGP 50.75 Increased By ▲ 0.15 (0.3%)
TELE 17.32 Increased By ▲ 0.28 (1.64%)
TRG 163.30 Increased By ▲ 0.80 (0.49%)
UNITY 41.31 Increased By ▲ 0.51 (1.25%)
WTL 3.64 Decreased By ▼ -0.03 (-0.82%)
BR100 5,187 Decreased By ▼ -1.84 (-0.04%)
BR30 26,295 Increased By ▲ 45.34 (0.17%)
KSE100 47,736 Decreased By ▼ -22.61 (-0.05%)
KSE30 19,099 Decreased By ▼ -10.59 (-0.06%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
23,575
4624hr
Pakistan Cases
1,047,999
4,72224hr
8.15% positivity
Sindh
389,699
Punjab
359,321
Balochistan
30,749
Islamabad
88,676
KPK
145,862
World

EU regulator finds possible link between J&J COVID-19 vaccine and blood clots

  • The European Medicines Agency (EMA) said its safety committee concluded that a warning about unusual blood clots with low blood platelets should be added to the vaccine's labels.
  • The EMA found that all instances had occurred in adults under 60 years, mostly women, within three weeks of vaccination, adding that all available evidence, including eight reports of cases in the United States, were part of its assessment.
Updated 20 Apr 2021

Europe's drug regulator said on Tuesday it had found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who had received the shot in the United States.

The European Medicines Agency (EMA) said its safety committee concluded that a warning about unusual blood clots with low blood platelets should be added to the vaccine's labels.

The EMA found that all instances had occurred in adults under 60 years, mostly women, within three weeks of vaccination, adding that all available evidence, including eight reports of cases in the United States, were part of its assessment.

It also said that most clots had occurred in the brain and abdomen, similar to AstraZeneca's vaccine, and reiterated that the vaccine's overall benefits outweigh risks.